Literature DB >> 20590837

Mitochondrial haplogroups associated with lifestyle-related diseases and longevity in the Japanese population.

Yutaka Nishigaki1, Noriyuki Fuku, Masashi Tanaka.   

Abstract

Recently published results on the association between metabolic syndrome, type 2 diabetes, myocardial infarction or atherothrombotic cerebral infarction and Japanese major haplogroups based on the comprehensive analysis of mitochondrial genome polymorphisms (mtSNP) in the coding region of human mitochondrial DNA (mtDNA), and longevity-related haplogroups are described in the present review. Our aim was to provide information that would allow us to predict the genetic risk for lifestyle-related diseases and thereby contribute to the primary prevention of these conditions. The mitochondrial genome variation is so large that a given haplogroup might consist of various subhaplogroups carrying unique and presumably functional mtSNP. The frequency of each subhaplogroup is sometimes only a few percent. Therefore, large-scale association study is necessary for elucidating the impact of each subhaplogroup on the susceptibility to various common diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590837     DOI: 10.1111/j.1447-0594.2010.00599.x

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  15 in total

Review 1.  Human mitochondrial DNA: roles of inherited and somatic mutations.

Authors:  Eric A Schon; Salvatore DiMauro; Michio Hirano
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

Review 2.  Blood-based bioenergetics: An emerging translational and clinical tool.

Authors:  Andrea Braganza; Gowtham K Annarapu; Sruti Shiva
Journal:  Mol Aspects Med       Date:  2019-12-18

Review 3.  Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure.

Authors:  Sarah Wong; Cecilia Giulivi
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

4.  T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.

Authors:  Todd Hulgan; Gregory K Robbins; Spyros A Kalams; David C Samuels; Benjamin Grady; Robert Shafer; Deborah G Murdock; Doug Selph; David W Haas; Richard B Pollard
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

5.  Mitochondrial DNA sequence variation in Finnish patients with matrilineal diabetes mellitus.

Authors:  Heidi K Soini; Jukka S Moilanen; Saara Finnila; Kari Majamaa
Journal:  BMC Res Notes       Date:  2012-07-10

6.  May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?

Authors:  Elena Caldarazzo Ienco; Costanza Simoncini; Daniele Orsucci; Loredana Petrucci; Massimiliano Filosto; Michelangelo Mancuso; Gabriele Siciliano
Journal:  Int J Alzheimers Dis       Date:  2011-02-22

7.  Prevalence of at-risk genotypes for genotoxic effects decreases with age in a randomly selected population in Flanders: a cross sectional study.

Authors:  Hans B Ketelslegers; Roger W L Godschalk; Ralph W H Gottschalk; Ad M Knaapen; Gudrun Koppen; Greet Schoeters; Willy F Baeyens; Vera Nelen; Joep P M Geraedts; Joost H M van Delft; Jos C S Kleinjans; Nicolas A van Larebeke
Journal:  Environ Health       Date:  2011-10-05       Impact factor: 5.984

8.  Pathways to aging: the mitochondrion at the intersection of biological and psychosocial sciences.

Authors:  Martin Picard
Journal:  J Aging Res       Date:  2011-09-26

9.  The mitochondrial DNA Northeast Asia CZD haplogroup is associated with good disease-free survival among male oral squamous cell carcinoma patients.

Authors:  Chih-Hsiung Lai; Shiang-Fu Huang; I-How Chen; Chun-Ta Liao; Hung-Ming Wang; Ling-Ling Hsieh
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Redox metabolism abnormalities in autistic children associated with mitochondrial disease.

Authors:  R E Frye; R Delatorre; H Taylor; J Slattery; S Melnyk; N Chowdhury; S J James
Journal:  Transl Psychiatry       Date:  2013-06-18       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.